PULSE OXIMETRY, CAPNOGRAPHY AND RELATED PATIENT MONITORING TECHNOLOGIES

NHS Supply Chain seeks to establish a non-exclusive Framework Agreement for supply to NHS Supply Chain depots via the Stock/Blue Diamond routes and to the NHS Supply Chain customer base via the E-Direct Routes.

The Framework Agreement is for the supply of pulse oximetry, capnography and related patient monitoring technologies, for monitoring five key base modalities:

- Saturated Pulse Oximetry (SPO2),

- Endtidal Carbon Dioxide (ETCO2),

- Near Infra-red Spectroscopy (NIRS),

- Transcutaneous Carbon Dioxide Partial Pressure (PCO2),

- Depth of Anaesthesia.

It is anticipated that in the first 24 months of the Framework Agreement the value of purchases will be circa 38 028 398 GBP. For the full 48 month term (if extended) the anticipated value is circa 85 380 944 GBP.

These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business.